These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 27281496)

  • 1. First-line chemotherapy in low-risk gestational trophoblastic neoplasia.
    Lawrie TA; Alazzam M; Tidy J; Hancock BW; Osborne R
    Cochrane Database Syst Rev; 2016 Jun; 2016(6):CD007102. PubMed ID: 27281496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First-line chemotherapy in low-risk gestational trophoblastic neoplasia.
    Alazzam M; Tidy J; Hancock BW; Osborne R; Lawrie TA
    Cochrane Database Syst Rev; 2012 Jul; 7(7):CD007102. PubMed ID: 22786502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First line chemotherapy in low risk gestational trophoblastic neoplasia.
    Alazzam M; Tidy J; Hancock BW; Osborne R
    Cochrane Database Syst Rev; 2009 Jan; (1):CD007102. PubMed ID: 19160319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination chemotherapy for primary treatment of high-risk gestational trophoblastic tumour.
    Deng L; Zhang J; Wu T; Lawrie TA
    Cochrane Database Syst Rev; 2013 Jan; 2013(1):CD005196. PubMed ID: 23440800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The efficacy and safety of first-line single-agent chemotherapy regimens in low-risk gestational trophoblastic neoplasia: A network meta-analysis.
    Li J; Li S; Yu H; Wang J; Xu C; Lu X
    Gynecol Oncol; 2018 Feb; 148(2):247-253. PubMed ID: 29203174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylactic chemotherapy for hydatidiform mole to prevent gestational trophoblastic neoplasia.
    Wang Q; Fu J; Hu L; Fang F; Xie L; Chen H; He F; Wu T; Lawrie TA
    Cochrane Database Syst Rev; 2017 Sep; 9(9):CD007289. PubMed ID: 28892119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of low-risk gestational trophoblastic neoplasia comparing biweekly eight-day Methotrexate with folinic acid versus bolus-dose Actinomycin-D, among Brazilian women.
    Uberti EM; Fajardo Mdo C; da Cunha AG; Frota SS; Braga A; Ayub AC
    Rev Bras Ginecol Obstet; 2015 Jun; 37(6):258-65. PubMed ID: 26200823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotherapy for resistant or recurrent gestational trophoblastic neoplasia.
    Alazzam M; Tidy J; Osborne R; Coleman R; Hancock BW; Lawrie TA
    Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD008891. PubMed ID: 26760424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are different methotrexate regimens as first line therapy for low risk gestational trophoblastic neoplasia more cost effective than the dactinomycin regimen used in GOG 0174?
    Miller CR; Chappell NP; Sledge C; Leath CA; Phippen NT; Havrilesky LJ; Barnett JC
    Gynecol Oncol; 2017 Jan; 144(1):125-129. PubMed ID: 27816248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prophylactic chemotherapy for hydatidiform mole to prevent gestational trophoblastic neoplasia.
    Fu J; Fang F; Xie L; Chen H; He F; Wu T; Hu L; Lawrie TA
    Cochrane Database Syst Rev; 2012 Oct; 10(10):CD007289. PubMed ID: 23076934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotherapy for resistant or recurrent gestational trophoblastic neoplasia.
    Alazzam M; Tidy J; Osborne R; Coleman R; Hancock BW; Lawrie TA
    Cochrane Database Syst Rev; 2012 Dec; 12():CD008891. PubMed ID: 23235667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pegylated liposomal doxorubicin for relapsed epithelial ovarian cancer.
    Newhouse R; Nelissen E; El-Shakankery KH; Rogozińska E; Bain E; Veiga S; Morrison J
    Cochrane Database Syst Rev; 2023 Jul; 7(7):CD006910. PubMed ID: 37407274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparing biweekly single-dose actinomycin D with multiday methotrexate therapy for low-risk gestational trophoblastic neoplasia (FIGO Score 0-4): study protocol for a prospective, multicentre, randomized trial.
    Jiang F; Mao MY; Xiang Y; Lu X; Guan CL; Jiao LZ; Wan XR; Feng FZ; Ren T; Yang JJ; Zhao J
    BMC Cancer; 2023 Aug; 23(1):784. PubMed ID: 37612621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct comparisons of efficacy and safety between actinomycin-D and methotrexate in women with low-risk gestational trophoblastic neoplasia: a meta-analysis of randomized and high-quality non-randomized studies.
    Hao J; Zhou W; Zhang M; Yu H; Zhang T; An R; Xue Y
    BMC Cancer; 2021 Oct; 21(1):1122. PubMed ID: 34663255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Actinomycin d versus methotrexate-folinic acid as the treatment of stage I, low-risk gestational trophoblastic neoplasia: a randomized controlled trial.
    Lertkhachonsuk AA; Israngura N; Wilailak S; Tangtrakul S
    Int J Gynecol Cancer; 2009 Jul; 19(5):985-8. PubMed ID: 19574798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medical methods for first trimester abortion.
    Zhang J; Zhou K; Shan D; Luo X
    Cochrane Database Syst Rev; 2022 May; 5(5):CD002855. PubMed ID: 35608608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An international randomized phase III trial of pulse actinomycin-D versus multi-day methotrexate for the treatment of low risk gestational trophoblastic neoplasia; NRG/GOG 275.
    Schink JC; Filiaci V; Huang HQ; Tidy J; Winter M; Carter J; Anderson N; Moxley K; Yabuno A; Taylor SE; Kushnir C; Horowitz N; Miller DS
    Gynecol Oncol; 2020 Aug; 158(2):354-360. PubMed ID: 32460997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interventions for treating genital Chlamydia trachomatis infection in pregnancy.
    Cluver C; Novikova N; Eriksson DO; Bengtsson K; Lingman GK
    Cochrane Database Syst Rev; 2017 Sep; 9(9):CD010485. PubMed ID: 28937705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparing and evaluating the efficacy of methotrexate and actinomycin D as first-line single chemotherapy agents in low risk gestational trophoblastic disease.
    Lee YJ; Park JY; Kim DY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
    J Gynecol Oncol; 2017 Mar; 28(2):e8. PubMed ID: 27819410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant gonadotropin-releasing hormone analogues for the prevention of chemotherapy-induced premature ovarian failure in premenopausal women.
    Chen H; Xiao L; Li J; Cui L; Huang W
    Cochrane Database Syst Rev; 2019 Mar; 3(3):CD008018. PubMed ID: 30827035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.